Explore Silence Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SLN. Silence Therapeutics' Phase 2 data shows zerlasiran achieves over 80% ...
Today is shaping up negative for Silence Therapeutics plc (NASDAQ:SLN) shareholders, with the analysts delivering a substantial negative revision to this year's forecasts. There was a fairly ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback